Showing 1 - 10 of 618
Persistent link: https://www.econbiz.de/10010389412
Persistent link: https://www.econbiz.de/10012193457
Persistent link: https://www.econbiz.de/10014429330
This article examines the market power of branded prescription drugs faced with generic competition. Using prescription-level and matched socioeconomic panel data of the entire Swedish population between 2010 and 2016, I provide evidence for the key role of switching costs. A discontinuity...
Persistent link: https://www.econbiz.de/10012161505
This paper studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries...
Persistent link: https://www.econbiz.de/10014158749
This article examines the market power of branded prescription drugs faced with generic competition. Using prescription-level and matched socioeconomic panel data of the entire Swedish population between 2010 and 2016, I provide evidence for the key role of switching costs. A discontinuity...
Persistent link: https://www.econbiz.de/10014095430
This paper provides field evidence on (a) how price framing affects consumers' decision to switch health insurance plans and (b) how the price elasticity of demand for health insurance can be influenced by policymakers through simple regulatory efforts. In 2009, in order to foster competition...
Persistent link: https://www.econbiz.de/10011601065
Steigende Kosten in den meisten Gesundheitssystemen und die damit verbundenen Finanzierungsprobleme stehen im Focus von vielen empirischen Untersuchungen. Wissenschaftler sind der Meinung, dass falsch gesetzte Anreize einer der Hauptgründe hierfür darstellen. Die vorliegende Arbeit umreißt...
Persistent link: https://www.econbiz.de/10010262920
Deductibles in health insurance are often regarded as a means to contain health care costs when individuals exhibit moral hazard. However, in the absence of moral hazard, voluntarily chosen deductibles may instead lead to self-selection into different insurance contracts. We use a set of new...
Persistent link: https://www.econbiz.de/10010264745
The German health care reform of 2004 imposes a charge of 10 Euro for the first visit to a doctor in each quarter of the year. At first glance, there is no inhibiting effect of this fee on utilization in the German Socio-Economic Panel. However, this study reveals that the true effect is...
Persistent link: https://www.econbiz.de/10010427543